_id
690da820ccc777a4e85d07bf
Ticker
ABDXF
Name
Abingdon Health Plc
Exchange
PINK
Address
York Biotech Campus, York, United Kingdom, YO41 1LZ
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.abingdonhealth.com
Description
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Last Close
0.07
Volume
10000
Current Price
0.07
Change
0
Last Updated
2026-01-21T18:44:23.031Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
13266611
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
3870903
Cost Of Revenue
1910000
Gross Profit
1184000
Operating Expenses
3825000
Operating Income
-2641000
Interest Expense
50044
Pretax Income
-2633000
Net Income
-3154023
Eps
-0.008893580602246216
Dividends Per Share
-
Shares Outstanding
189523008
Income Tax Expense
-140123
EBITDA
-1964000
Operating Margin
-68.22697442948066
Total Other Income Expense Net
8000
Cash
3671000
Short Term Investments
-
Receivables
1745000
Inventories
444000
Total Current Assets
6180000
Property Plant Equipment
798000
Total Assets
9822000
Payables
2304000
Short Term Debt
276885
Long Term Debt
741000
Total Liabilities
3401000
Equity
6421000
Bs_currency_symbol
GBP
Depreciation
267000
Change In Working Capital
345000
Cash From Operations
-2684860
Capital Expenditures
7506
Cash From Investing
-1487557
Cash From Financing
6963622
Net Change In Cash
2772196
Cf_currency_symbol
-
PE
-
PB
3.86619344961844
ROE
-49.120432954368475
ROA
-32.111820403176544
FCF
-2692366
Fcf Percent
-0.6955395162317423
Piotroski FScore
0
Health Score
25
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
2
Value Investing Score
3
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
3870903
Quarters > 0 > income Statement > cost Of Revenue
1910000
Quarters > 0 > income Statement > gross Profit
1184000
Quarters > 0 > income Statement > operating Expenses
3825000
Quarters > 0 > income Statement > operating Income
-2641000
Quarters > 0 > income Statement > interest Expense
50044
Quarters > 0 > income Statement > pretax Income
-2633000
Quarters > 0 > income Statement > net Income
-3154023
Quarters > 0 > income Statement > eps
-0.008893580602246216
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
354640402
Quarters > 0 > income Statement > income Tax Expense
-140123
Quarters > 0 > income Statement > EBITDA
-1964000
Quarters > 0 > income Statement > operating Margin
-68.22697442948066
Quarters > 0 > income Statement > total Other Income Expense Net
8000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3671000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1745000
Quarters > 0 > balance Sheet > inventories
444000
Quarters > 0 > balance Sheet > total Current Assets
6180000
Quarters > 0 > balance Sheet > property Plant Equipment
798000
Quarters > 0 > balance Sheet > total Assets
9822000
Quarters > 0 > balance Sheet > payables
2304000
Quarters > 0 > balance Sheet > short Term Debt
276885
Quarters > 0 > balance Sheet > long Term Debt
741000
Quarters > 0 > balance Sheet > total Liabilities
3401000
Quarters > 0 > balance Sheet > equity
6421000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-2521000
Quarters > 0 > cash Flow > depreciation
267000
Quarters > 0 > cash Flow > change In Working Capital
345000
Quarters > 0 > cash Flow > cash From Operations
-2684860
Quarters > 0 > cash Flow > capital Expenditures
7506
Quarters > 0 > cash Flow > cash From Investing
-1487557
Quarters > 0 > cash Flow > cash From Financing
6963622
Quarters > 0 > cash Flow > net Change In Cash
2772196
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.008893580602246216
Quarters > 0 > ratios > PB
3.86619344961844
Quarters > 0 > ratios > ROE
-49.120432954368475
Quarters > 0 > ratios > ROA
-32.111820403176544
Quarters > 0 > ratios > FCF
-2692366
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.6955395162317423
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
3725000
Quarters > 1 > income Statement > cost Of Revenue
1324000
Quarters > 1 > income Statement > gross Profit
2401000
Quarters > 1 > income Statement > operating Expenses
2562000
Quarters > 1 > income Statement > operating Income
-161000
Quarters > 1 > income Statement > interest Expense
18000
Quarters > 1 > income Statement > pretax Income
-179000
Quarters > 1 > income Statement > net Income
-66000
Quarters > 1 > income Statement > eps
-0.00021608108572390442
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
305440894
Quarters > 1 > income Statement > income Tax Expense
-113000
Quarters > 1 > income Statement > EBITDA
-1000
Quarters > 1 > income Statement > operating Margin
-4.322147651006712
Quarters > 1 > income Statement > total Other Income Expense Net
-18000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1440000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1442000
Quarters > 1 > balance Sheet > inventories
441000
Quarters > 1 > balance Sheet > total Current Assets
3548000
Quarters > 1 > balance Sheet > property Plant Equipment
997000
Quarters > 1 > balance Sheet > total Assets
5090000
Quarters > 1 > balance Sheet > payables
605000
Quarters > 1 > balance Sheet > short Term Debt
120000
Quarters > 1 > balance Sheet > long Term Debt
722000
Quarters > 1 > balance Sheet > total Liabilities
2841000
Quarters > 1 > balance Sheet > equity
2249000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-66000
Quarters > 1 > cash Flow > depreciation
141000
Quarters > 1 > cash Flow > change In Working Capital
-475000
Quarters > 1 > cash Flow > cash From Operations
-460000
Quarters > 1 > cash Flow > capital Expenditures
17000
Quarters > 1 > cash Flow > cash From Investing
-27000
Quarters > 1 > cash Flow > cash From Financing
-71000
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.00021608108572390442
Quarters > 1 > ratios > PB
9.506830849266342
Quarters > 1 > ratios > ROE
-2.9346376167185415
Quarters > 1 > ratios > ROA
-1.2966601178781925
Quarters > 1 > ratios > FCF
-477000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.12805369127516777
Quarters > 1 > health Score
16
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
1205000
Quarters > 2 > income Statement > cost Of Revenue
1417000
Quarters > 2 > income Statement > gross Profit
-212000
Quarters > 2 > income Statement > operating Expenses
2738000
Quarters > 2 > income Statement > operating Income
-1745000
Quarters > 2 > income Statement > interest Expense
34000
Quarters > 2 > income Statement > pretax Income
-610000
Quarters > 2 > income Statement > net Income
-1205000
Quarters > 2 > income Statement > eps
-0.003963377288711419
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
304033634
Quarters > 2 > income Statement > income Tax Expense
-15000
Quarters > 2 > income Statement > EBITDA
-447000
Quarters > 2 > income Statement > operating Margin
-144.81327800829874
Quarters > 2 > income Statement > total Other Income Expense Net
1135000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1998000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
999000
Quarters > 2 > balance Sheet > inventories
411000
Quarters > 2 > balance Sheet > total Current Assets
3754000
Quarters > 2 > balance Sheet > property Plant Equipment
977000
Quarters > 2 > balance Sheet > total Assets
4822000
Quarters > 2 > balance Sheet > payables
2000000
Quarters > 2 > balance Sheet > short Term Debt
97000
Quarters > 2 > balance Sheet > long Term Debt
721000
Quarters > 2 > balance Sheet > total Liabilities
3008000
Quarters > 2 > balance Sheet > equity
1814000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1205000
Quarters > 2 > cash Flow > depreciation
285000
Quarters > 2 > cash Flow > change In Working Capital
33000
Quarters > 2 > cash Flow > cash From Operations
-1173000
Quarters > 2 > cash Flow > capital Expenditures
22000
Quarters > 2 > cash Flow > cash From Investing
2000
Quarters > 2 > cash Flow > cash From Financing
-43000
Quarters > 2 > cash Flow > net Change In Cash
-1238000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.003963377288711419
Quarters > 2 > ratios > PB
11.73227915104741
Quarters > 2 > ratios > ROE
-66.42778390297684
Quarters > 2 > ratios > ROA
-24.989630858564908
Quarters > 2 > ratios > FCF
-1195000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.991701244813278
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
2934000
Quarters > 3 > income Statement > cost Of Revenue
1490000
Quarters > 3 > income Statement > gross Profit
1444000
Quarters > 3 > income Statement > operating Expenses
2678000
Quarters > 3 > income Statement > operating Income
-1234000
Quarters > 3 > income Statement > interest Expense
41000
Quarters > 3 > income Statement > pretax Income
-1150000
Quarters > 3 > income Statement > net Income
-1030000
Quarters > 3 > income Statement > eps
-0.0033877830766578937
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
304033634
Quarters > 3 > income Statement > income Tax Expense
-120000
Quarters > 3 > income Statement > EBITDA
-188000
Quarters > 3 > income Statement > operating Margin
-42.05862304021814
Quarters > 3 > income Statement > total Other Income Expense Net
659000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
3236000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
699000
Quarters > 3 > balance Sheet > inventories
329000
Quarters > 3 > balance Sheet > total Current Assets
4762000
Quarters > 3 > balance Sheet > property Plant Equipment
1209000
Quarters > 3 > balance Sheet > total Assets
6061000
Quarters > 3 > balance Sheet > payables
1111000
Quarters > 3 > balance Sheet > short Term Debt
87000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3052000
Quarters > 3 > balance Sheet > equity
3009000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1030000
Quarters > 3 > cash Flow > depreciation
343000
Quarters > 3 > cash Flow > change In Working Capital
-631000
Quarters > 3 > cash Flow > cash From Operations
-995000
Quarters > 3 > cash Flow > capital Expenditures
99000
Quarters > 3 > cash Flow > cash From Investing
-98000
Quarters > 3 > cash Flow > cash From Financing
-121000
Quarters > 3 > cash Flow > net Change In Cash
-1214000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0033877830766578937
Quarters > 3 > ratios > PB
7.072899428381523
Quarters > 3 > ratios > ROE
-34.23064140910601
Quarters > 3 > ratios > ROA
-16.993895396799207
Quarters > 3 > ratios > FCF
-1094000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.3728698023176551
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
8429000
Annuals > 0 > income Statement > cost Of Revenue
4693000
Annuals > 0 > income Statement > gross Profit
3736000
Annuals > 0 > income Statement > operating Expenses
11938000
Annuals > 0 > income Statement > operating Income
-3509000
Annuals > 0 > income Statement > interest Expense
87000
Annuals > 0 > income Statement > pretax Income
-3496000
Annuals > 0 > income Statement > net Income
-3415000
Annuals > 0 > income Statement > eps
-0.01763665506536276
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
193630821
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-41.63008660576581
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1918000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1248000
Annuals > 0 > balance Sheet > inventories
526000
Annuals > 0 > balance Sheet > total Current Assets
5130000
Annuals > 0 > balance Sheet > property Plant Equipment
1044000
Annuals > 0 > balance Sheet > total Assets
9313000
Annuals > 0 > balance Sheet > payables
765000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
652000
Annuals > 0 > balance Sheet > total Liabilities
4013000
Annuals > 0 > balance Sheet > equity
5300000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-3415000
Annuals > 0 > cash Flow > depreciation
608000
Annuals > 0 > cash Flow > change In Working Capital
-542000
Annuals > 0 > cash Flow > cash From Operations
-3182000
Annuals > 0 > cash Flow > capital Expenditures
346000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
474000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.01763665506536276
Annuals > 0 > ratios > PB
2.5573882018867926
Annuals > 0 > ratios > ROE
-64.43396226415095
Annuals > 0 > ratios > ROA
-36.669172124986574
Annuals > 0 > ratios > FCF
-3528000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.4185549887293866
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
6135000
Annuals > 1 > income Statement > cost Of Revenue
2456000
Annuals > 1 > income Statement > gross Profit
3679000
Annuals > 1 > income Statement > operating Expenses
5052000
Annuals > 1 > income Statement > operating Income
-1373000
Annuals > 1 > income Statement > interest Expense
57000
Annuals > 1 > income Statement > pretax Income
-1399000
Annuals > 1 > income Statement > net Income
-1271000
Annuals > 1 > income Statement > eps
-0.004170874404030943
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
304732264
Annuals > 1 > income Statement > income Tax Expense
-128000
Annuals > 1 > income Statement > EBITDA
-916000
Annuals > 1 > income Statement > operating Margin
-22.379788101059496
Annuals > 1 > income Statement > total Other Income Expense Net
-26000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1440000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1442000
Annuals > 1 > balance Sheet > inventories
441000
Annuals > 1 > balance Sheet > total Current Assets
3548000
Annuals > 1 > balance Sheet > property Plant Equipment
997000
Annuals > 1 > balance Sheet > total Assets
5090000
Annuals > 1 > balance Sheet > payables
605000
Annuals > 1 > balance Sheet > short Term Debt
120000
Annuals > 1 > balance Sheet > long Term Debt
722000
Annuals > 1 > balance Sheet > total Liabilities
2841000
Annuals > 1 > balance Sheet > equity
2249000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1271000
Annuals > 1 > cash Flow > depreciation
426000
Annuals > 1 > cash Flow > change In Working Capital
-744000
Annuals > 1 > cash Flow > cash From Operations
-1659000
Annuals > 1 > cash Flow > capital Expenditures
41000
Annuals > 1 > cash Flow > cash From Investing
-23000
Annuals > 1 > cash Flow > cash From Financing
-114000
Annuals > 1 > cash Flow > net Change In Cash
-1796000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.004170874404030943
Annuals > 1 > ratios > PB
9.48477477990218
Annuals > 1 > ratios > ROE
-56.51400622498889
Annuals > 1 > ratios > ROA
-24.970530451866406
Annuals > 1 > ratios > FCF
-1700000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.27709861450692747
Annuals > 1 > health Score
17
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
4045000
Annuals > 2 > income Statement > cost Of Revenue
1970000
Annuals > 2 > income Statement > gross Profit
2075000
Annuals > 2 > income Statement > operating Expenses
5248000
Annuals > 2 > income Statement > operating Income
-3588000
Annuals > 2 > income Statement > interest Expense
75000
Annuals > 2 > income Statement > pretax Income
-3574000
Annuals > 2 > income Statement > net Income
-3469000
Annuals > 2 > income Statement > eps
-0.011409932008021106
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
304033363
Annuals > 2 > income Statement > income Tax Expense
-105000
Annuals > 2 > income Statement > EBITDA
-3173000
Annuals > 2 > income Statement > operating Margin
-88.70210135970333
Annuals > 2 > income Statement > total Other Income Expense Net
14000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
3236000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
699000
Annuals > 2 > balance Sheet > inventories
329000
Annuals > 2 > balance Sheet > total Current Assets
4762000
Annuals > 2 > balance Sheet > property Plant Equipment
1209000
Annuals > 2 > balance Sheet > total Assets
6061000
Annuals > 2 > balance Sheet > payables
1111000
Annuals > 2 > balance Sheet > short Term Debt
87000
Annuals > 2 > balance Sheet > long Term Debt
708000
Annuals > 2 > balance Sheet > total Liabilities
3052000
Annuals > 2 > balance Sheet > equity
3009000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-3451000
Annuals > 2 > cash Flow > depreciation
673000
Annuals > 2 > cash Flow > change In Working Capital
3672000
Annuals > 2 > cash Flow > cash From Operations
1002000
Annuals > 2 > cash Flow > capital Expenditures
157000
Annuals > 2 > cash Flow > cash From Investing
-67000
Annuals > 2 > cash Flow > cash From Financing
-7000
Annuals > 2 > cash Flow > net Change In Cash
839000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.011409932008021106
Annuals > 2 > ratios > PB
7.07289312396145
Annuals > 2 > ratios > ROE
-115.28747092057161
Annuals > 2 > ratios > ROA
-57.23477973931694
Annuals > 2 > ratios > FCF
845000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.2088998763906057
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
2835000
Annuals > 3 > income Statement > cost Of Revenue
8064000
Annuals > 3 > income Statement > gross Profit
-5229000
Annuals > 3 > income Statement > operating Expenses
6876000
Annuals > 3 > income Statement > operating Income
-12105000
Annuals > 3 > income Statement > interest Expense
69000
Annuals > 3 > income Statement > pretax Income
-21685000
Annuals > 3 > income Statement > net Income
-21262000
Annuals > 3 > income Statement > eps
-0.07290929176767134
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
291622638
Annuals > 3 > income Statement > income Tax Expense
-423000
Annuals > 3 > income Statement > EBITDA
-19887000
Annuals > 3 > income Statement > operating Margin
-426.984126984127
Annuals > 3 > income Statement > total Other Income Expense Net
-65000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2397000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
8027000
Annuals > 3 > balance Sheet > inventories
534000
Annuals > 3 > balance Sheet > total Current Assets
10958000
Annuals > 3 > balance Sheet > property Plant Equipment
1777000
Annuals > 3 > balance Sheet > total Assets
12771000
Annuals > 3 > balance Sheet > payables
2471000
Annuals > 3 > balance Sheet > short Term Debt
265000
Annuals > 3 > balance Sheet > long Term Debt
435000
Annuals > 3 > balance Sheet > total Liabilities
6339000
Annuals > 3 > balance Sheet > equity
6432000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-21262000
Annuals > 3 > cash Flow > depreciation
1637000
Annuals > 3 > cash Flow > change In Working Capital
-5358000
Annuals > 3 > cash Flow > cash From Operations
-7735000
Annuals > 3 > cash Flow > capital Expenditures
760000
Annuals > 3 > cash Flow > cash From Investing
-760000
Annuals > 3 > cash Flow > cash From Financing
5915000
Annuals > 3 > cash Flow > net Change In Cash
-2580000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.07290929176767134
Annuals > 3 > ratios > PB
3.1737538339552245
Annuals > 3 > ratios > ROE
-330.56592039800995
Annuals > 3 > ratios > ROA
-166.48657113773393
Annuals > 3 > ratios > FCF
-8495000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.99647266313933
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.008893580602246216
Valuation > metrics > PB
3.86619344961844
Valuation > final Score
41.3380655038156
Valuation > verdict
28.9% Overvalued
Profitability > metrics > ROE
-49.120432954368475
Profitability > metrics > ROA
-51.035970873786404
Profitability > metrics > Net Margin
-0.8148029025785456
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5296682759694752
Risk > metrics > Interest Coverage
-52.7735592678443
Risk > final Score
-163
Risk > verdict
High
Liquidity > metrics > Current Ratio
-
Liquidity > metrics > Quick Ratio
-
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-6
Prev Risks > 1
-175
Prev Risks > 2
-90
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-21T18:44:23.704Z
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Abingdon Health Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.